![Jay Shepard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Shepard
Directeur/Membre du Conseil chez
ESPERION THERAPEUTICS, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Jay P.
Shepard was the founder of Relypsa, Inc., founded in 2007, serving as Director from 2008 to 2010.
Mr. Shepard was also the founder of Pathalys Pharma, Inc...
Current positions included Independent Director at Esperion Therapeutics, Inc. since 2018; Independent Director at Ironwood Pharmaceuticals, Inc. since 2020; Director at Santa Clara University; Independent Director at Inovio Pharmaceuticals, Inc. since 2020; Director at Craig Hospital; Independent Director at Altamont Pharma Acquisition Corp.; Outside Director at Aculys Pharma LLC; Director at Cessation Therapeutics, LLC; and Venture Partner at Catalys Pacific LLC.
Former positions include President, Chief Executive Officer & Director at NextWave Pharmaceuticals, Inc. from 2011 to 2012; President, Chief Executive Officer & Director at Ilypsa, Inc. from 2005 to 2008; President, CEO, CFO & Director at Versartis, Inc. from 2017 to 2018; Chairman at Aravive, Inc. in 2020; Director at InterMune, Inc.; Independent Director at DURECT Corp.; Independent Director at Immedica Pharma US, Inc.; Director at Sorbent Therapeutics, Inc.; Director at Bullet Biotechnology, Inc.; Director at Christopher & Dana Reeve Foundation from 2016 to 2020; Director at NeuroRecovery Technologies, Inc.; Vice President at ALZA Corp.; Vice President-Commercial Operations at Telik, Inc. from 2001 to 2005; Executive Partner at Sofinnova Investments, Inc. from 2008 to 2015; Principal at Syntex Laboratories, Inc.; Vice President-Oncology Business Unit at ALZA Pharmaceuticals from 1993 to 2000; Principal at Ortho Pharmaceutical Corp.; Executive Partner at Sofinnova Ventures from 2008 to 2015.
Education includes undergraduate studies at the University of Arizona.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 235 036 ( 0,14 % ) | 839 079 $ | 31/05/2026 | |
| 28/05/2026 | 164 472 ( 0,06 % ) | 514 797 $ | 31/05/2026 | |
| 20/05/2026 | 9 209 ( 0,01 % ) | 12 064 $ | 31/05/2026 |
Postes actifs de Jay Shepard
| Sociétés | Poste | Début |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 29/05/2018 |
| INOVIO PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 15/01/2020 |
| IRONWOOD PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 03/12/2020 |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific invests in companies located in Cayman Islands. The firm targets companies operating in the fields of health services and health technology. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Aculys Pharma LLC
 Aculys Pharma LLC BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company focused on neurological diseases | Directeur/Membre du Conseil | - |
Altamont Pharma Acquisition Corp.
 Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | - |
Craig Hospital
 Craig Hospital Hospital/Nursing ManagementHealth Services Provides rehabilitation services for people with spinal cord injury and traumatic brain injury | Directeur/Membre du Conseil | - |
Cessation Therapeutics, LLC
 Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Develops novel immunotherapy vaccine for addiction therapy | Directeur/Membre du Conseil | - |
Anciens postes connus de Jay Shepard
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jay Shepard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
30
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 30 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Health Technology |
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cardiovascular and renal diseases | Health Technology |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Health Technology |
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Develops immunotherapy products | Health Technology |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
 Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Christopher & Dana Reeve Foundation
 Christopher & Dana Reeve Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation/endowment | Miscellaneous |
Syntex Laboratories, Inc. | |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
ALZA Pharmaceuticals | |
Ortho Pharmaceutical Corp. | |
Craig Hospital
Craig Hospital Hospital/Nursing ManagementHealth Services Provides rehabilitation services for people with spinal cord injury and traumatic brain injury | Health Services |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
NeuroRecovery Technologies, Inc.
 NeuroRecovery Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Aravive, Inc.
 Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific invests in companies located in Cayman Islands. The firm targets companies operating in the fields of health services and health technology. It provides financing for early stage capital requirements. | Finance |
Altamont Pharma Acquisition Corp.
Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Sofinnova Ventures | |
Cessation Therapeutics, LLC
Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Develops novel immunotherapy vaccine for addiction therapy | Health Technology |
Aculys Pharma LLC
Aculys Pharma LLC BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company focused on neurological diseases | Health Technology |
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. BiotechnologyHealth Technology Operates as late-stage clinical biopharmaceutical company that develops therapeutics for chronic kidney disease | Health Technology |
